”Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health provider with any questions you may have regarding a medical condition.
If you've been diagnosed with type 2 diabetes, your doctor will likely prescribe one medication first: metformin.
Metformin has been around for decades, yet it remains the cornerstone of type 2 diabetes treatment. The 2025 ADA guidelines recommend it as first-line therapy for most patients.
Here's what you need to know about this widely used medication.
What Is Metformin?
A Brief History
- Discovered in the 1920s from French lilac (Galega officinalis)
- Approved for diabetes in the United States in 1994
- Prescribed to more than 150 million people worldwide
- On WHO's List of essential medicines
How It Works
Metformin works through three main mechanisms:
| Mechanism | Effect |
|---|---|
| Reduces liver glucose production | Lowers fasting blood sugar |
| Improves insulin sensitivity | Helps insulin work better |
| Decreases intestinal glucose absorption | Lowers post-meal blood sugar |
Unlike sulfonylureas, metformin does not stimulate insulin secretion—it makes your body more sensitive to the insulin you already produce.
Why Metformin Is First-Line Treatment
The Evidence
The UK Prospective Diabetes Study (UKPDS) established metformin as the gold standard:
| Benefit | Evidence |
|---|---|
| A1C reduction | 1.0-1.5% average |
| Cardiovascular protection | 39% reduction in myocardial infarction |
| Mortality benefit | 36% reduction in all-cause mortality |
| Durability | Effective for many years |
| Safety profile | Generally well-tolerated |
| Cost | Inexpensive (generic available) |
Advantages Over Other Medications
| Advantage | Explanation |
|---|---|
| No hypoglycemia | Doesn't stimulate insulin secretion |
| Weight neutral | Doesn't cause weight gain (may promote slight loss) |
| Cardiovascular benefit | Proven to reduce heart attacks |
| Long safety record | Prescribed for decades |
| Inexpensive | Often $4-$25/month without insurance |
| Dose once or twice daily | Convenient |
Who Should Take Metformin?
The 2025 ADA guidelines recommend metformin for:
| Situation | Recommendation |
|---|---|
| At diagnosis | Start immediately for most patients |
| High-risk prediabetes | Consider (BMI ≥ 35, age ＜ 60, prior GDM) |
| BMI 25-34.9 | First-line therapy |
| BMI ≥ 35 | First-line, consider adding GLP-1 or SGLT2 |
| With ASCVD | Combine with SGLT2 or GLP-1 |
Contraindications (Who Should NOT Take Metformin)
| Contraindication | Why |
|---|---|
| Severe kidney disease (eGFR ＜ 30) | Risk of lactic acidosis |
| Acute hypersensitivity | Allergic reaction |
| Metabolic acidosis | Could worsen condition |
| Severe liver disease | Impaired clearance |
| Binge alcohol use | Increased lactic acidosis risk |
| Pregnancy | Generally switched to insulin (though some use continues) |
| Certain imaging studies | Hold before/after IV contrast |
Dosage and Administration
Starting Dose
The standard approach is to start low and go slow:
| Week | Dosage | Purpose |
|---|---|---|
| Week 1 | 500 mg once daily with dinner | Minimize GI side effects |
| Week 2 | 500 mg twice daily (breakfast, dinner) | Continue tolerance assessment |
| Week 3 | 1000 mg with breakfast, 500 mg with dinner | Increase toward target |
| Week 4+ | 1000 mg twice daily OR 2000 mg ER once daily | Target therapeutic dose |
Maximum Effective Dose
- Standard dose: 2000 mg/day
- Maximum dose: 2550 mg/day (rarely needed)
- Most patients: Reach 1500-2000 mg/day for full effect
Immediate-Release vs. Extended-Release
| Formulation | Dosing | Best For |
|---|---|---|
| Immediate-release (IR) | Twice daily with meals | Lower cost, flexible dosing |
| Extended-release (ER/XR) | Once daily with dinner | Fewer side effects, convenience |
Tip: If switching from IR to ER, use the same total daily dose.
Side Effects
Common Side Effects (Usually Temporary)
| Side Effect | Frequency | Management |
|---|---|---|
| Diarrhea | 30% | Start low, go slow; take with food; consider ER formulation |
| Nausea | 20% | Take with food; split doses |
| Abdominal discomfort | 15% | Time to meals; ER formulation |
| Metallic taste | 5-10% | Usually resolves within weeks |
Good news: Side effects typically improve within 2-4 weeks as your body adjusts.
Strategies to Minimize GI Side Effects
- Start with 500 mg once daily with dinner
- Increase gradually over several weeks
- Always take with food
- Consider extended-release formulation
- Don't crush or chew ER tablets
Rare but Serious: Lactic Acidosis
Incidence: Approximately 3 cases per 100,000 patient-years (very rare)
| Risk Factor | Why It Matters |
|---|---|
| Severe kidney impairment (eGFR ＜ 30) | Reduced clearance |
| Contrast dye studies | Temporary kidney stress |
| Excessive alcohol use | Increases lactate production |
| Acute illness (dehydration, infection) | Kidney stress |
| Liver disease | Impaired lactate metabolism |
Symptoms: Muscle pain, weakness, trouble breathing, abdominal pain, nausea/vomiting, cold feeling
Prevention:
- Hold metformin before procedures with IV contrast
- Monitor kidney function periodically
- Avoid excessive alcohol
- Stay hydrated during illness
Metformin and Kidney Function
The 2025 Guidelines
Kidney function determines whether metformin can be used:
| eGFR (mL/min/1.73 m²) | Recommendation |
|---|---|
| ≥ 45 | Full dose |
| 30-44 | Assess benefit/risk; consider reducing dose; do not start |
| <30 | Contraindicated |
Key change: Previous guidelines limited use below eGFR 60. New evidence supports use down to eGFR 45, and caution to 30.
Monitoring
- Check eGFR at baseline before starting
- Check annually if stable
- Check before IV contrast studies
- Resume when kidney function stabilizes after procedures
Metformin Beyond Blood Sugar
Cardiovascular Benefits
Unlike many diabetes medications, metformin has proven cardiovascular benefit:
- Reduced heart attacks (UKPDS: 39% reduction)
- Reduced cardiovascular mortality (UKPDS: 42% reduction)
- Benefit persists for decades (10-year follow-up showed continued benefit)
Other Potential Benefits
| Potential Benefit | Evidence Strength |
|---|---|
| Weight loss (1-3 kg) | Moderate |
| PCOS improvement | Strong (off-label use) |
| Cancer risk reduction | Observational data |
| Cognitive benefit | Mixed evidence |
| Longevity | Some evidence in diabetes |
PCOS (Off-Label Use)
Metformin is frequently prescribed for polycystic ovary syndrome:
- Improves insulin resistance
- May help with weight loss
- Can improve menstrual regularity
- May improve fertility
Metformin and Vitamin B12
The Connection
Long-term metformin use is associated with vitamin B12 deficiency:
- Incidence: 10-30% of long-term users
- Mechanism: Altered B12 absorption in the gut
- Timeline: Deficiency develops over years
Recommendations
The 2025 guidelines suggest:
- Periodic B12 monitoring in patients on metformin
- Especially in those with:
- Anemia or neuropathy
- Vegetarian/vegan diet
- Long-term use (> 4 years)
Symptoms of B12 Deficiency
- Fatigue, weakness
- Numbness, tingling in hands/feet
- Difficulty walking
- Glossitis (swollen tongue)
- Cognitive changes
Management: B12 supplements (oral 1000 mcg daily often sufficient).
Metformin in Special Populations
Pregnancy
Traditionally, insulin was preferred in pregnancy. However:
- Growing evidence supports metformin safety in pregnancy
- Increasingly used for gestational diabetes
- Many providers continue metformin in early pregnancy (discuss with your OB)
If planning pregnancy: Discuss options with your healthcare provider.
Older Adults
Benefits:
- Low hypoglycemia risk
- Cardiovascular protection
- Inexpensive
Considerations:
- Start at lower doses (500 mg daily)
- Increase more slowly
- Monitor kidney function regularly
- Avoid if eGFR ＜ 30
Adolescents
- FDA-approved for children ≥ 10 years old
- First-line for pediatric type 2 diabetes
- Dosing: Start 500 mg once daily, titrate to 2000 mg/day
Metformin and Other Medications
Commonly Combined With
| Medication Class | Rationale |
|---|---|
| Sulfonylureas | Complementary mechanisms |
| SGLT2 inhibitors | Additive glucose lowering; cardiovascular benefit |
| GLP-1 agonists | Additive glucose lowering; weight loss synergy |
| DPP-4 inhibitors | Additive glucose lowering; well-tolerated |
| Insulin | Reduces insulin dose needed; limits weight gain |
Medication Interactions
| Interaction | Effect |
|---|---|
| Cimetidine | May increase metformin levels |
| Carbonic anhydrase inhibitors | Increased lactic acidosis risk |
| Alcohol | Increases lactic acidosis risk (chronic use) |
Key Takeaways
- Metformin is first-line therapy for most type 2 diabetes patients
- Start low, go slow to minimize GI side effects
- Does not cause hypoglycemia when used alone
- Proven cardiovascular benefit—reduces heart attacks and mortality
- Monitor kidney function and hold for procedures with IV contrast
- Check B12 periodically with long-term use
- Extended-release formulation may reduce side effects
FAQ Section
What is metformin used for?
Metformin is primarily used to treat type 2 diabetes by lowering blood sugar. It works by reducing glucose production in the liver and improving insulin sensitivity. It's also used off-label for PCOS and sometimes for prediabetes.
Does metformin cause weight loss?
Metformin is weight neutral overall, but many patients experience modest weight loss of 1-3 kg (2-7 lbs). It doesn't cause weight gain like some other diabetes medications (insulin, sulfonylureas, TZDs).
What are the side effects of metformin?
The most common side effects are gastrointestinal: diarrhea, nausea, abdominal discomfort, and metallic taste. These usually improve within a few weeks. Rare but serious is lactic acidosis, especially with kidney impairment.
Can I take metformin if I have kidney disease?
Metformin can be used with mild to moderate kidney disease (eGFR ≥ 45 mL/min/1.73 m²). It should not be started if eGFR is 30-45, and is contraindicated if eGFR ＜ 30. Kidney function should be monitored periodically.
What time of day should I take metformin?
Metformin should be taken with meals to reduce stomach upset. Immediate-release is typically taken twice daily with breakfast and dinner. Extended-release is usually taken once daily with dinner. Follow your doctor's specific instructions.
Sources:
- American Diabetes Association. Standards of Care in Diabetes—2025. Diabetes Care 2025; 48(Suppl 1)
- UKPDS Group. Lancet 1998;352:837-853 (metformin cardiovascular benefit)
- ADA Metformin Information